Barinthus Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	117.77	142.09	194.39	214.05	43.27	11.43
Cash & Short-Term Investments	117.77	142.09	194.39	214.05	43.27	11.43
Cash Growth	-31.93%	-26.90%	-9.19%	394.74%	278.46%	-
Accounts Receivable	-	-	5.85	0.02	0.52	0.99
Other Receivables	5.67	7.94	6.31	6.93	3.01	2.92
Receivables	5.67	7.94	12.16	6.95	3.53	3.91
Prepaid Expenses	7.81	5.4	5.89	4.61	1.08	0.91
Other Current Assets	0.63	1.47	0.61	1.15	0.03	-
Total Current Assets	131.88	156.91	213.04	226.77	47.9	16.25
Property, Plant & Equipment	18.25	19.4	15.71	9.09	2.77	2.79
Goodwill	12.21	12.21	12.21	12.63	-	-
Other Intangible Assets	23.53	25.11	28.27	31.43	-	-
Other Long-Term Assets	0.89	0.88	0.98	0.8	-	-
Total Assets	186.75	214.51	270.21	280.72	50.67	19.04
Accounts Payable	2.56	1.6	3.75	2.42	4.67	3.89
Accrued Expenses	10.28	9.21	8.06	7.88	2.54	1.42
Short-Term Debt	-	-	-	0.16	-	-
Current Portion of Leases	1.92	1.79	0.43	0.52	0.19	0.17
Current Unearned Revenue	0.84	-	-	0.18	0.25	0.27
Total Current Liabilities	15.59	12.6	12.24	11.16	7.64	5.75
Long-Term Debt	-	-	-	-	44.7	-
Long-Term Leases	10.65	11.19	8.34	6.54	1.47	1.61
Long-Term Deferred Tax Liabilities	0.49	0.57	3.75	8.08	-	-
Other Long-Term Liabilities	3.23	3.15	2.68	2.37	-	-
Total Liabilities	29.96	27.51	27	28.15	53.81	7.36
Common Stock	0	0	0	0	-	0
Additional Paid-In Capital	390.27	386.6	379.5	369.1	21.66	15.91
Retained Earnings	-209.01	-176.59	-103.24	-108.59	-57.72	-37.89
Comprehensive Income & Other	-24.65	-23.23	-33.37	-8.39	-1.24	-0.47
Total Common Equity	156.62	186.78	242.9	252.13	-37.3	-22.45
Minority Interest	0.17	0.21	0.31	0.44	0.39	0.37
Shareholders' Equity	156.79	187	243.2	252.56	-3.15	11.69
Total Liabilities & Equity	186.75	214.51	270.21	280.72	50.67	19.04
Total Debt	12.57	12.98	8.77	7.22	46.36	1.78
Net Cash (Debt)	105.2	129.11	185.61	206.83	-3.1	9.65
Net Cash Growth	-34.60%	-30.44%	-10.26%	-	-	-
Net Cash Per Share	2.72	3.36	4.86	7.99	-0.39	411.37
Filing Date Shares Outstanding	39.41	38.92	38.34	37.19	0.03	0.02
Total Common Shares Outstanding	39.18	38.64	37.68	37.19	0.03	0.02
Working Capital	116.29	144.31	200.8	215.61	40.26	10.5
Book Value Per Share	4.00	4.83	6.45	6.78	-1447.99	-953.22
Tangible Book Value	120.88	149.47	202.42	208.07	-37.3	-22.45
Tangible Book Value Per Share	3.08	3.87	5.37	5.59	-1447.99	-953.22
Machinery	-	6.84	5.35	2.09	1.06	0.77
Leasehold Improvements	-	8.67	3.93	0.63	0.05	-

Source: S&P Capital IQ. Standard template. Financial Sources.